Literature DB >> 11058207

Influence of asthma education on asthma severity, quality of life and environmental control.

J Côté1, A Cartier, P Robichaud, H Boutin, J L Malo, M Rouleau, L P Boulet.   

Abstract

BACKGROUND: Several studies have examined the influence of asthma education, focusing mainly on the use of health services.
OBJECTIVES: To assess the influence of an asthma education program (AEP) on airway responsiveness, asthma symptoms, patient quality of life (QOL) and environmental control.
DESIGN: A prospective, randomized, controlled study with parallel groups.
SETTING: Three tertiary care hospitals in Quebec. POPULATION: One hundred and eighty-eight patients with moderate to severe asthma. INTERVENTION: After optimization of asthma treatment with inhaled corticosteroids, patients were randomly assigned to receive either an education program based on self-management (group E) or usual care (control group C).
RESULTS: One year after an AEP, there was a significant decrease in the number of days per month without daytime asthma symptoms in group E only (P=0.03). Asthma daily symptom scores decreased significantly in group E in comparison with group C (P=0. 006). QOL scores improved markedly in both groups after treatment optimization during the run-in period (P<0.01). After an AEP, the QOL score increased further in group E patients in comparison with group C patients (P=0.04). The concentration of methacholine that induces a 20% fall in forced expiratory volume in 1 s (PC20) improved significantly in both groups (group E 1.2+/-1.1 to 2.4+/-0. 2, group C 1.5+/-1.2 to 2.4+/-1.3, P<0.01). After one year, 26 of 37 patients from group E sensitized to house dust mites (HDM) adopted the specific measures recommended to reduce their exposure to HDM, while none of the 21 subjects from group C did (P<0.001). Among the patients sensitized to cats or dogs, 15% of patients from group E and 23% of patients in group C no longer had a pet at home at the final visit (P>0.5).
CONCLUSIONS: One year after the educational intervention, it was observed that the program had added value over and above that of optimization of medication and regular clinical follow-ups. The education program was highly effective in promoting HDM avoidance measures but minimally effective for removing domestic animals, suggesting that more efficient strategies need to be developed for the latter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058207     DOI: 10.1155/2000/787980

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  10 in total

1.  Factors associated with nonresponse to a computer-tailored asthma management program for urban adolescents with asthma.

Authors:  C L M Joseph; S L Havstad; D Johnson; J Saltzgaber; E L Peterson; K Resnicow; D R Ownby; A P Baptist; C C Johnson; V J Strecher
Journal:  J Asthma       Date:  2010-08       Impact factor: 2.515

Review 2.  Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003.

Authors:  Allan Becker; Catherine Lemière; Denis Bérubé; Louis-Philippe Boulet; Francine M Ducharme; Mark FitzGerald; Thomas Kovesi
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

3.  Household endotoxin reduction in the Louisa Environmental Intervention Project for rural childhood asthma.

Authors:  Angelico Mendy; Nervana Metwali; Sarah S Perry; Elizabeth A Chrischilles; Kai Wang; Peter S Thorne
Journal:  Indoor Air       Date:  2019-11-22       Impact factor: 5.770

4.  The CASE survey: patient and physician perceptions regarding asthma medication use and associated oropharyngeal symptoms.

Authors:  J M Fitzgerald; C Kn Chan; M C Holroyde; Louis-Philippe Boulet
Journal:  Can Respir J       Date:  2008 Jan-Feb       Impact factor: 2.409

5.  Asthma counselling targeted to removal of domestic animals.

Authors:  L Hagan; P Valois; H Patenaude; H Boutin; Louis-Philippe Boulet; F Lafrenière
Journal:  Can Respir J       Date:  2008 Jan-Feb       Impact factor: 2.409

6.  Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD.

Authors:  Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

7.  The need for nursing instruction in patients receiving steroid pulse therapy for the treatment of autoimmune diseases and the effect of instruction on patient knowledge.

Authors:  Yu-Chu Pai
Journal:  BMC Musculoskelet Disord       Date:  2010-09-21       Impact factor: 2.362

8.  2003 canadian asthma consensus guidelines executive summary.

Authors:  Allan Becker; Catherine Lemière; Denis Bérubé; Louis-Philippe Boulet; Francine Ducharme; Mark Fitzgerald; Thomas Kovesi
Journal:  Allergy Asthma Clin Immunol       Date:  2006-03-15       Impact factor: 3.406

9.  Poor asthma education and medication compliance are associated with increased emergency department visits by asthmatic children.

Authors:  Saleh Al-Muhsen; Nour Horanieh; Said Dulgom; Zohair Al Aseri; Alejandro Vazquez-Tello; Rabih Halwani; Hamdan Al-Jahdali
Journal:  Ann Thorac Med       Date:  2015 Apr-Jun       Impact factor: 2.219

10.  [A randomised clinical trial to evaluate the effectiveness of an educational intervention developed for adult asthmatics in a primary care centre].

Authors:  Gloria Cano Fuentes; Carmen Dastis Bendala; Isabel Morales Barroso; M Luisa Manzanares Torné; Andrés Fernández Gregorio; Leticia Martín Romana
Journal:  Aten Primaria       Date:  2013-10-29       Impact factor: 1.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.